Cargando…
High acceptability and viral suppression of patients on Dolutegravir-based first-line regimens in pilot sites in Uganda: A mixed-methods prospective cohort study
Uganda adopted the integrase inhibitor dolutegravir (DTG) as part its preferred first-line HIV treatment regimen in 2018. Prior to the national rollout, the Uganda Ministry of Health and Clinton Health Access Initiative (CHAI) launched a pilot study in July 2017 aimed at better understanding patient...
Autores principales: | Nabitaka, Vennie Mbaziira, Nawaggi, Pamela, Campbell, Jennifer, Conroy, James, Harwell, Joseph, Magambo, Kinanga, Middlecote, Caroline, Caldwell, Benvy, Katureebe, Cordelia, Namuwenge, Norah, Atugonza, Rita, Musoke, Andrew, Musinguzi, Joshua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252626/ https://www.ncbi.nlm.nih.gov/pubmed/32459822 http://dx.doi.org/10.1371/journal.pone.0232419 |
Ejemplares similares
-
Results from a proactive follow-up intervention to improve linkage and retention among people living with HIV in Uganda: a pre-/post- study
por: Boeke, Caroline E., et al.
Publicado: (2018) -
Assessing linkage to and retention in care among HIV patients in Uganda and identifying opportunities for health systems strengthening: a descriptive study
por: Boeke, Caroline E., et al.
Publicado: (2018) -
A prospective cohort study of outcomes for isoniazid prevention therapy: a nested study from a national QI collaborative in Uganda
por: Sensalire, Simon, et al.
Publicado: (2020) -
High acceptability and viral suppression rate for first-Line patients on a dolutegravir-based regimen: An early adopter study in Nigeria
por: Abudiore, Opeyemi, et al.
Publicado: (2023) -
Adherence to antiretroviral therapy and retention in care for adolescents living with HIV from 10 districts in Uganda
por: Nabukeera-Barungi, Nicolette, et al.
Publicado: (2015)